Thymectomy immediately after myasthenic crisis

  • Vesna Martić Military Medical Academy, Clinic for Neurology, Belgrade, Serbia
  • Nebojša Marić University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Dragan Djordjević University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Keywords: myasthenia gravis, diagnosis, thymectomy, critical illness, treatment outcome

Abstract


Introduction. Myasthenic crisis (MC) refers to rapid progression of myasthenic weakness accompanied by ventilatory and bulbar dysfunction. Since there is no single standard accepted in the treatment of every patient in myasthenic crisis, we report our experience in the treatment of such a patient. Case report. We report a 22-year-old male patient with clinical, pharmacological, neurophysiological, and immunological diagnosis of seropositive generalized myastenia gravis (MG) of unstable course. During the first 6 months of his disease, three deteriorations were registered, and the last one developed into a myasthenic crisis. The patient was intubated. Previous anticholinergic and imunosuppresive therapies were withdrawn, and he was treated with plasma exchange and human immunoglobulins during the crisis. After thymectomy, performed 3 weeks after extubation, the patient was stable. Conclusion. Progress in treatment of MC over the last few decades has dramatically improved its prognosis. Thymectomy is useful in the prevention of MC recurrence.

References

Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myas-thenia gravis: Executive summary. Neurology 2016; 87(4): 419–25.

Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neurol 2004; 24(1): 75–81.

Liu Z, Yao S, Zhou Q, Deng Z, Zou J, Feng H, et al. Predictors of extubation outcomes following myasthenic crisis. J Int Med Res 2016; 44(6): 1524‒33.

Chaudhuri A, Behan PO. Myasthenic crisis. QJM 2009; 102(2): 97–107.

Stetefeld HR, Schroeter M. Myasthenic Crisis. Fortschr Neurol Psychiatr 2018; 86(5): 301‒7.

Lizarraga AA, Lizarraga KJ, Benatar M. Getting Rid of Weak-ness in the ICU: An Updated Approach to the Acute Man-agement of Myasthenia Gravis and Guillain-Barré Syndrome. Semin Neurol 2016; 36(6): 615‒24.

Roper J, Fleming ME, Long B, Koyfman A. Myasthenia Gravis and Crisis: Evaluation and Management in the Emergency Department. J Emerg Med 2017; 53(6): 843‒53.

Jani-Acsadi A, Lisak RP. Myasthenic crisis: guidelines for pre-vention and treatment. J Neurol Sci 2007; 261(1‒2): 127‒33.

Godoy DA, Mello LJ, Masotti L, Di Napoli M. The myasthenic patient in crisis: an update of the management in Neurointen-sive Care Unit. Arq Neuropsiquiatr 2013; 71(9A): 627–39.

Liu N, Liu Q, Wu X, Liu K, Vadis Q. Predictors of outcome of myasthenic crisis. Neurol Sci 2015; 36(5): 801–2.

Onuki T, Ueda S Otsu S, Yanagihara T, Kawakami N, Yamaoka M, et al. Thymectomy during Myasthenic Crisis under Artifi-cial Respiration. Ann Thorac Cardiovasc Surg 2019; 25(4): 215‒8.

Published
2021/08/24
Section
Case report